Twelve year observation of primary and secondary antibiotic-resistant Helicobacter pylori strains in children

被引:41
作者
Bontems, P
Devaster, JM
Corvaglia, L
Dezsöfi, A
van den Borre, C
Goutier, S
Butzler, JP
Cadranel, S
机构
[1] Queen Fabiola Childrens Hosp, Dept Pediat Gastroenterol Hepatol, B-1020 Brussels, Belgium
[2] Free Univ Brussels, Brugmann Univ Hosp, Dept Microbiol, Brussels, Belgium
关键词
Helicobacter pylori; antibiotic resistance; treatment; children;
D O I
10.1097/00006454-200111000-00006
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The effectiveness of Helicobacter pylori eradication regimens is influenced by an. tibiotic susceptibility of infecting strains. Data concerning antibiotic resistance in children are limited. We report the evolution of primary and secondary resistance in a series of Belgian children during the last 12 years. Patients and methods. From 1989 through 2000, H. pylori gastritis was diagnosed in 569 children, and antibiotic susceptibility tests were performed in 555. Eradication, using different schemes, failed in 128 of 457 treated children. After eradication failure antibiotic susceptibility determination was performed in 87 of 128. Comparison of antibiotic susceptibility of strains isolated from the gastric body and from the antrum was performed in 238 samples. Results. Resistance to amoxicillin was not observed. The rate of primary resistance to nitroimidazole derivatives was 18.0% (101 of 555) and remained constant throughout this period, whereas primary resistance to macrolides increased from an average of 6.0% (range, 0 to 10%) before 1995 to 16.6% (range, 10 to 25%, P < 0.001) thereafter. Antibiotic consumption in Belgium, especially macrolides, did not show important fluctuations during the study period. Secondary resistance developed in 39 of 87 patients (46%). Strains isolated from different gastric locations show identical susceptibility testing in all but 5 of 238. Conclusions. Resistance of H. pylori to macrolides increased in our pediatric population which did not appear to correlate with macrolides prescription habits in our country. After eradication failure acquired secondary resistance was observed in one-half of the patients.
引用
收藏
页码:1033 / 1038
页数:6
相关论文
共 40 条
[1]   Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin -: Influence on treatment outcome [J].
Adamek, RJ ;
Suerbaum, S ;
Pfaffenbach, B ;
Opferkuch, W .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1998, 93 (03) :386-389
[2]   Review article: immunological determinants that may affect the Helicobacter pylori cancer risk [J].
Blanchard, TG ;
Czinn, SJ .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1998, 12 :83-90
[3]   Clinical economics review: Helicobacter pylori-associated peptic ulcer disease [J].
Bodger, K ;
Daly, MJ ;
Heatley, RV .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (02) :273-282
[4]   Detection of Helicobacter pylori infection in children with a standardized and simplified 13C-Urea breath test [J].
Cadranel, S ;
Corvaglia, L ;
Bontems, P ;
Deprez, C ;
Glupczynski, Y ;
Van Riet, A ;
Keppens, E .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1998, 27 (03) :275-280
[5]  
CADRANEL S, 1996, MEDICAMENTS REFLUX G, P179
[6]  
De Koster E, 1999, GUT, V45, pA44
[7]  
DHAENENS L, 1996, INT J EPIDEMIOL, V25, P894
[8]   Classification and grading of gastritis - The updated Sydney System [J].
Dixon, MF ;
Genta, RM ;
Yardley, JH ;
Correa, P ;
Batts, KP ;
Dahms, BB ;
Filipe, MI ;
Haggitt, RC ;
Haot, J ;
Hui, PK ;
Lechago, J ;
Lewin, K ;
Offerhaus, JA ;
Price, AB ;
Riddell, RH ;
Sipponen, P ;
Solcia, E ;
Watanabe, H .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1996, 20 (10) :1161-1181
[9]  
Drumm Brendan, 2000, JPGN, V30, P207, DOI 10.1097/00005176-200002000-00020
[10]  
Ellenrieder V, 1999, SCAND J GASTROENTERO, V34, P750, DOI 10.1080/003655299750025660